Greg G. Wolff

425 total citations
9 papers, 306 citations indexed

About

Greg G. Wolff is a scholar working on Infectious Diseases, Pharmacology and Oncology. According to data from OpenAlex, Greg G. Wolff has authored 9 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in Greg G. Wolff's work include SARS-CoV-2 and COVID-19 Research (2 papers), Influenza Virus Research Studies (2 papers) and Bone health and treatments (2 papers). Greg G. Wolff is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Influenza Virus Research Studies (2 papers) and Bone health and treatments (2 papers). Greg G. Wolff collaborates with scholars based in United States. Greg G. Wolff's co-authors include Lois Lamerato, Gerry Oster, Kathryn Richert-Boe, Andrew G. Glass, Akshara Richhariya, John Edelsberg, Arun Balakumaran, Karen Chung, Gergana Zlateva and Jack Mardekian and has published in prestigious journals such as Vaccine, Supportive Care in Cancer and Peritoneal Dialysis International.

In The Last Decade

Greg G. Wolff

9 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg G. Wolff United States 7 118 69 57 55 51 9 306
Uzma Rasheed Pakistan 9 65 0.6× 45 0.7× 41 0.7× 149 2.7× 66 1.3× 39 327
Yiyuan Wu United States 9 64 0.5× 34 0.5× 77 1.4× 17 0.3× 100 2.0× 32 368
Parita Patel United States 11 61 0.5× 52 0.8× 38 0.7× 25 0.5× 69 1.4× 27 332
Fuxiang Liang China 8 22 0.2× 41 0.6× 37 0.6× 28 0.5× 57 1.1× 22 315
Neeraj Chhabra United States 9 77 0.7× 23 0.3× 21 0.4× 8 0.1× 40 0.8× 37 285
Thamer A Hamdan Germany 10 22 0.2× 130 1.9× 20 0.4× 28 0.5× 80 1.6× 35 298
Sudhir Bhandari India 10 62 0.5× 42 0.6× 15 0.3× 172 3.1× 31 0.6× 46 355
Lisa Kennedy United States 7 38 0.3× 85 1.2× 26 0.5× 15 0.3× 51 1.0× 11 569
D. Jane Holmes–Walker Australia 16 24 0.2× 243 3.5× 40 0.7× 29 0.5× 21 0.4× 34 576
İbrahim Halil Kurt Türkiye 13 20 0.2× 195 2.8× 75 1.3× 18 0.3× 52 1.0× 80 511

Countries citing papers authored by Greg G. Wolff

Since Specialization
Citations

This map shows the geographic impact of Greg G. Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg G. Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg G. Wolff more than expected).

Fields of papers citing papers by Greg G. Wolff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg G. Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg G. Wolff. The network helps show where Greg G. Wolff may publish in the future.

Co-authorship network of co-authors of Greg G. Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of Greg G. Wolff. A scholar is included among the top collaborators of Greg G. Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg G. Wolff. Greg G. Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Lee, David T., et al.. (2019). Causeway. 1–12. 5 indexed citations
3.
Wolff, Greg G., et al.. (2015). Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents. Vaccine. 33(28). 3228–3233. 6 indexed citations
4.
Park, Peter W., et al.. (2015). Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States. Pain Practice. 16(8). 1001–1011. 47 indexed citations
5.
Lamerato, Lois, et al.. (2015). Prevalence of Chronic Pain in a Large Integrated Healthcare Delivery System in the U.S.A. Pain Practice. 16(7). 890–898. 15 indexed citations
6.
Oster, Gerry, Lois Lamerato, Andrew G. Glass, et al.. (2014). Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Supportive Care in Cancer. 22(5). 1363–1373. 25 indexed citations
7.
Taneja, Charu, Ariel Berger, Gary Inglese, et al.. (2014). Can Dialysis Patients be Accurately Identified using Healthcare Claims Data?. Peritoneal Dialysis International. 34(6). 643–651. 14 indexed citations
8.
Oster, Gerry, Lois Lamerato, Andrew G. Glass, et al.. (2013). Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Supportive Care in Cancer. 21(12). 3279–3286. 120 indexed citations
9.
Pedersen, Elin Rønby & Greg G. Wolff. (2008). Paper interface to electronic medical records. 40–49. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026